Group One Trading’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATOS
Group One Trading's ATOS Position: Q3 2026 in Review
Group One Trading sold out of Atossa Therapeutics (ATOS) in Q3 2026, closing a stake of 54 shares — an estimated $129 sold.
Group One Trading first reported a position in ATOS in Q2 2019 and held it in 22 quarters. The position peaked at $10.4M in Q2 2021. 35 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.
- Group One Trading reported no remaining Atossa Therapeutics position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 54 Atossa Therapeutics shares in Q3 2026, an estimated $129.
- Group One Trading first reported a position in Atossa Therapeutics in Q2 2019 and held it in 22 quarters.
- Group One Trading's Atossa Therapeutics position peaked at $10.4M in Q2 2021.
- 35 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.